Cargando…
The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer
Hyaluronic acid (HA) receptor CD44 is widely used for identifying cancer stem cells and its activation promotes stemness. Recent evidence shows that overexpression of CD44 is associated with poor prognosis in most human cancers and mediates therapy resistance. For these reasons, in recent years, CD4...
Autor principal: | Cirillo, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649834/ https://www.ncbi.nlm.nih.gov/pubmed/37958796 http://dx.doi.org/10.3390/ijms242115812 |
Ejemplares similares
-
Hyaluronan, a double-edged sword in kidney diseases
por: Kaul, Aditya, et al.
Publicado: (2021) -
Inflammasomes in cancer: a double-edged sword
por: Kolb, Ryan, et al.
Publicado: (2014) -
Double-edged sword.
Publicado: (1994) -
Glutathione in Ovarian Cancer: A Double-Edged Sword
por: Nunes, Sofia C., et al.
Publicado: (2018) -
Antibiotics for cancer treatment: A double-edged sword
por: Gao, Yuan, et al.
Publicado: (2020)